HLA

Scope & Guideline

Shaping the Future of Allergy Research Through Collaboration

Introduction

Explore the comprehensive scope of HLA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore HLA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2059-2302
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge2011, from 2016 to 2024
AbbreviationHLA / HLA
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'HLA' focuses on the study of human leukocyte antigens (HLA) and their implications for immunology, transplantation, and disease associations. It serves as a platform for disseminating research that advances the understanding of HLA genetics, molecular biology, and clinical applications.
  1. Characterization of Novel HLA Alleles:
    The journal emphasizes the identification and characterization of new HLA alleles through advanced sequencing techniques, which are crucial for understanding genetic diversity and its implications in transplantation and disease susceptibility.
  2. HLA and Disease Associations:
    Research on the association between specific HLA alleles and various diseases, including autoimmune disorders, infectious diseases, and cancers, is a core focus. This includes studies linking HLA polymorphisms to clinical outcomes and disease severity.
  3. Transplantation Immunology:
    The journal covers topics related to HLA's role in transplantation, particularly in understanding donor-recipient compatibility, the development of donor-specific antibodies, and strategies for improving transplant outcomes.
  4. Molecular and Genetic Techniques:
    A significant portion of the research employs next-generation sequencing and other molecular techniques to explore HLA genetics, focusing on high-resolution typing and the implications of genetic variations.
  5. Immunogenetics and Personalized Medicine:
    The integration of immunogenetics into personalized medicine approaches, particularly in transplantation and autoimmune diseases, is a growing area of interest, reflecting the journal's commitment to translational research.
The journal is experiencing a dynamic evolution in its focus areas, with several emerging themes gaining prominence. These trends reflect advancements in technology and shifts in clinical practice.
  1. Next-Generation Sequencing Applications:
    The use of next-generation sequencing for HLA typing and allele discovery is increasingly prominent, enabling more efficient and accurate identification of alleles and enhancing understanding of genetic diversity.
  2. HLA in COVID-19 Research:
    Research linking HLA alleles to COVID-19 susceptibility and outcomes is rapidly emerging, reflecting the pandemic's impact on immunogenetics and highlighting the relevance of HLA in infectious disease response.
  3. Immunogenetic Factors in Transplant Outcomes:
    There is a growing trend towards researching the impact of specific HLA alleles and haplotypes on transplant outcomes, particularly in relation to donor-specific antibodies and graft-versus-host disease.
  4. Integration of Machine Learning in HLA Studies:
    The application of machine learning techniques in analyzing HLA data for predicting transplant outcomes and understanding immunological responses is emerging as a significant trend, indicating a shift towards data-driven approaches.
  5. Personalized Medicine in Transplantation:
    Increasingly, studies are focusing on personalized medicine approaches in transplantation, including the customization of immunosuppressive therapies based on HLA profiles and patient-specific factors.

Declining or Waning

While the journal has seen significant growth in certain areas, there are themes that appear to be declining in prominence. These waning scopes indicate shifts in research focus or decreased publication activity.
  1. HLA Typing Methodologies:
    Research specifically centered on traditional HLA typing methodologies seems to be declining, as there is a noticeable shift towards next-generation sequencing and more advanced molecular techniques.
  2. HLA Antibody Detection Techniques:
    The exploration of older methodologies for HLA antibody detection, such as complement-dependent cytotoxicity assays, has seen reduced publication frequency as newer, more sensitive techniques gain traction.
  3. General HLA Research without Specific Clinical Application:
    There appears to be a waning interest in purely academic studies of HLA without direct clinical implications, as the focus shifts towards translational research that can impact patient care and treatment outcomes.

Similar Journals

Frontiers in Genetics

Elevating Genetic Research to New Heights
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

JOURNAL OF MEDICAL GENETICS

Pioneering Insights in Medical Genetics Since 1965.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-2593Frequency: 12 issues/year

JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

Application of Clinical Genetics

Elevating Standards in Clinical Genetics Scholarship
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Application of Clinical Genetics is a premier open-access journal published by Dove Medical Press Ltd., dedicated to advancing the field of clinical genetics since its inception in 2008. Based in New Zealand, this journal has established itself as a significant resource for researchers, clinicians, and students alike, contributing to the body of knowledge in both genetic medicine and clinical applications. With an impact factor reflecting its contributions to the field, the journal holds positions in the Q2 and Q3 quartiles of the 2023 Genetics categories, showcasing its relevance and scientific merit. Furthermore, it ranks #43 out of 99 in Clinical Genetics and #153 out of 347 in Biochemistry, Genetics, and Molecular Biology, indicating robust performance amongst its peers. The journal’s broad scope, encompassing various aspects of clinical genetics, ensures that it remains at the forefront of critical discussions, innovative research, and applications essential for the progression of personalized medicine. Researchers and professionals are encouraged to explore its openly accessible content that fosters collaboration and the sharing of knowledge in this dynamic and rapidly evolving field.

Human Genetics and Genomics Advances

Connecting Researchers, Empowering Insights
Publisher: ELSEVIERISSN: 2666-2477Frequency:

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

ACTA BIOCHIMICA POLONICA

Exploring the Frontiers of Biochemical Knowledge
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Gene Reports

Transforming Genetic Discoveries into Practical Solutions
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

GENES AND IMMUNITY

Transforming Research in Genetics and Immune Science
Publisher: SPRINGERNATUREISSN: 1466-4879Frequency: 8 issues/year

GENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.

Genetic Testing and Molecular Biomarkers

Advancing the Future of Genetic Research.
Publisher: MARY ANN LIEBERT, INCISSN: 1945-0265Frequency: 12 issues/year

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

IMMUNOLOGICAL INVESTIGATIONS

Navigating the Evolving Landscape of Immunological Investigations
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0139Frequency: 8 issues/year

IMMUNOLOGICAL INVESTIGATIONS, published by Taylor & Francis Inc, is a leading journal in the field of immunology and related medical sciences, with an established presence since 1972. With a focus on cutting-edge research and critical insights in immunological methods and theories, this journal serves as a pivotal platform for researchers, professionals, and students alike. Though it currently holds a Q3 ranking in Immunology and a Q2 ranking in miscellaneous medicine as of 2023, its Scopus rank of #129 out of 236 reflects its dedication to advancing the understanding of immune responses and therapies. The journal's commitment to rigorous peer review and high-quality publications enables it to remain relevant and influential in the ever-evolving landscape of immunological research. Subscription is required to access its extensive archive, which spans critical developments in the field of immunology from 1972 to 2024.

HUMAN GENETICS

Advancing the frontiers of genetics research.
Publisher: SPRINGERISSN: 0340-6717Frequency: 12 issues/year

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.